Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
Recruiting
N/A
Interventional Study
Lung Cancer (Diagnosis)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 30 (estimated)
- Sponsor
- University of Vienna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
* indication for mediastinal staging
Exclusion Criteria:
\-
Contacts